Clinical Trials Browser

Phase NA × Carcinoma, Hepatocellular × lenvatinib × Clear all

NCT07417800 2026-02-18

Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning

Phase NA Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06740370 2025-08-14

TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT07077798 2025-07-22

Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection

Phase NA Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT06622031 2025-01-13

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06061276 2024-09-23

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT04618367 2024-03-06

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04642547 2023-08-01

Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT04967495 2023-05-18

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT03838796 2022-08-02

Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT05391867 2022-05-26

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT05339581 2022-04-27

iPLENTY-pvtt

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04443049 2021-10-05

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT04531228 2021-09-22

Thalen

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT04961138 2021-07-14

Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT04443322 2020-09-22

Dulect2020-1

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms